TRAVERE THERAPEUTICS INC. - COMMON STOCK
19.49
14-三月-25 13:52:59
15 分钟延时
股票
+0.36
+1.88%
今日范围
18.86 - 19.87
ISIN
N/A
来源
NASDAQ
-
Travere Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
15 2月 2024 15:01:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results
08 2月 2024 15:30:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics to Present at the Guggenheim 6th Annual Biotechnology Conference
01 2月 2024 15:30:00 条件 Nasdaq GlobeNewswire
-
25 1月 2024 15:05:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Provides Corporate Update and 2024 Outlook
08 1月 2024 06:00:01 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
02 1月 2024 15:30:00 条件 Nasdaq GlobeNewswire
-
14 12月 2023 06:30:00 条件 Nasdaq GlobeNewswire
-
04 12月 2023 15:05:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics to Present at the 6th Annual Evercore ISI HealthCONx Conference
21 11月 2023 15:30:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Third Quarter 2023 Financial Results
07 11月 2023 15:01:01 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics to Report Third Quarter 2023 Financial Results
24 10月 2023 15:30:00 条件 Nasdaq GlobeNewswire
-
13 10月 2023 15:30:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 10月 2023 16:00:00 条件 Nasdaq GlobeNewswire
-
26 9月 2023 15:30:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 9月 2023 16:00:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Completes Sale of Bile Acid Product Portfolio to Mirum Pharmaceuticals
05 9月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics to Present at the 2023 Wells Fargo Healthcare Conference
31 8月 2023 15:30:00 条件 Nasdaq GlobeNewswire
-
24 8月 2023 15:30:00 条件 Nasdaq GlobeNewswire